International Patent: GENETICALLY MODIFIED IMMUNE CELL, AND CONSTRUCTION AND USE THEREOF

GENEVA, July 9 -- BIOSYNGEN (GUANGZHOU) CO., LTD. filed a patent application (CN2025/070735) for “GENETICALLY MODIFIED IMMUNE CELL, AND CONSTRUCTION AND USE THEREOF”. With publication no. WO/2026/143707, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 15/85

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....